By Counterforce Health Team in Thiola / Thiola EC (tiopronin) —

How to Get Thiola (Tiopronin) Covered by Blue Cross Blue Shield of Illinois: Forms, Appeals, and PA Process

Answer Box: Getting Thiola Covered in Illinois

Thiola (tiopronin) requires prior authorization from Blue Cross Blue Shield of Illinois for most plans. The fastest path to approval: (1) Submit the BCBSIL Prior Authorization Request Form with cystinuria diagnosis (ICD-10: E72.0), 24-hour urine cystine levels, and documentation of failed conservative therapy; (2) Use Accredo specialty pharmacy (833-721-1619) for prescription fulfillment; (3) If denied, file internal appeal within 30 days, then external review through Illinois Department of Insurance within 30 days if needed. Illinois residents have strong appeal rights under the Health Carrier External Review Act.

Table of Contents

  1. Verify Your Plan and Coverage
  2. Prior Authorization Forms and Requirements
  3. Submission Portals and Process
  4. Specialty Pharmacy Setup
  5. Appeals Process in Illinois
  6. Common Denial Reasons and Solutions
  7. Support Resources and Contacts
  8. Cost Assistance Programs
  9. When to Escalate

Verify Your Plan and Coverage

Before starting the prior authorization process, confirm your Blue Cross Blue Shield of Illinois plan type and Thiola's coverage status.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for most BCBSIL plans Performance Drug List BCBSIL Drug List
Specialty Pharmacy Must use in-network providers HMO Specialty Network Network List
Medical Necessity Cystinuria diagnosis required Clinical criteria PA Guidelines
Appeal Deadline 30 days for internal appeal Illinois law IDOI External Review

First step: Call the member services number on your insurance card to verify:

  • Whether Thiola requires PA for your specific plan
  • Your specialty pharmacy network requirements
  • Current formulary tier and any quantity limits

Prior Authorization Forms and Requirements

Required Documentation

Blue Cross Blue Shield of Illinois requires comprehensive clinical documentation for Thiola approval:

Essential Elements:

  1. Diagnosis: Cystinuria with ICD-10 code E72.0
  2. Lab Results: 24-hour urine cystine levels (typically >250 mg/day indicates need for treatment)
  3. Conservative Therapy Trial: Documentation of adequate trial and failure of:
    • High fluid intake (3-4 liters daily)
    • Urinary alkalinization (potassium citrate)
    • Dietary modifications (low sodium, moderate protein)
  4. Stone History: Previous cystine stones or high risk factors
  5. Provider Specialty: Nephrology or urology consultation preferred

Medical Necessity Letter Checklist

Clinician Corner: Your medical necessity letter should address these key points:Confirmed cystinuria diagnosis with genetic testing or family historyQuantified 24-hour urine cystine excretionDocumented failure or intolerance of conservative measuresRisk of recurrent stone formation without treatmentThiola's mechanism as a cystine-binding agentMonitoring plan for effectiveness and side effects

Include citations to:

Submission Portals and Process

Electronic Submission (Preferred)

Availity Provider Portal: BCBSIL's preferred method for PA submissions

  • Log in at Availity Essentials
  • Upload supporting documents electronically
  • Track approval status in real-time
  • Faster processing than fax/mail submissions

Alternative Submission Methods

If electronic submission isn't available:

Fax: Use the PA fax number listed in your provider manual (verify current number with BCBSIL)

Mail: Send to the address specified in the Prior Authorization Request Form

Tip: Include a cover sheet with member ID, prescriber NPI, and "URGENT - Rare Disease Medication" to expedite processing.

Processing Timeline

  • Standard PA: 15 business days for determination
  • Expedited PA: 24-72 hours if medical urgency documented
  • Appeal Review: 30 days for internal, 5 business days for external review

Specialty Pharmacy Setup

Thiola requires dispensing through BCBSIL's specialty pharmacy network.

Primary Specialty Pharmacies

Accredo Specialty Pharmacy (Primary for self-administered specialty drugs)

Rush Specialty Drug Solutions (For select HMO plans)

Transfer Process

  1. For New Prescriptions: E-prescribe directly to Accredo or call to initiate
  2. Existing Prescriptions: Patient calls Accredo to transfer from current pharmacy
  3. Required Information: Insurance card, prescriber contact, current medication list
Note: Out-of-network specialty pharmacies may result in full cost responsibility for the patient.

Appeals Process in Illinois

Illinois provides robust appeal rights under the Health Carrier External Review Act.

Step-by-Step Appeals Process

1. Internal Appeal (Required First Step)

  • Deadline: 30 calendar days from denial notice
  • Submission: Via Availity portal or mail/fax
  • Required: Denial letter, clinical documentation, provider authorization
  • Timeline: 15 business days for standard, 24-72 hours for expedited

2. External Review (If Internal Appeal Denied)

  • Deadline: 30 days from internal appeal denial (stricter than most states)
  • Process: File with Illinois Department of Insurance
  • Cost: Free to patient (insurer pays IRO fees)
  • Timeline: 5 business days for decision
  • Reviewer: Board-certified physician with relevant expertise

Expedited Appeals

Request expedited review if:

  • Delay would seriously jeopardize health
  • Risk of recurrent kidney stones requiring emergency intervention
  • Previous severe stone complications

Call the member services number on your ID card and state: "I need an expedited appeal for a medically necessary medication."

Common Denial Reasons and Solutions

Denial Reason How to Overturn Required Documentation
No cystinuria diagnosis Submit genetic testing or family history ICD-10 E72.0, lab reports
Conservative therapy not tried Document trial and failure/intolerance Provider notes, patient diary
Quantity limits exceeded Justify higher dose medically Weight-based dosing rationale
Not medically necessary Emphasize rare disease status FDA orphan drug designation
Missing prior authorization Resubmit with complete documentation All required forms and labs

Sample Appeal Language

When appealing a denial, include this language:

"Cystinuria is a rare genetic disorder affecting approximately 1 in 7,000 individuals. Thiola (tiopronin) is FDA-approved specifically for preventing cystine stone formation when conservative measures are insufficient. The patient has documented cystinuria with elevated urinary cystine excretion and has failed conservative therapy including adequate hydration and alkalinization. Denial of this orphan drug for an FDA-approved indication constitutes inappropriate restriction of medically necessary care."

Support Resources and Contacts

BCBSIL Contact Information

Member Services: Number on your insurance ID card Provider Services: 877-627-6337 (Prime Therapeutics) Prior Authorization Status: Blue Access for Providers portal

Illinois Consumer Assistance

Illinois Department of Insurance

  • Consumer Hotline: 877-527-9431
  • External Review: File online
  • Office of Consumer Health Insurance assistance

Illinois Attorney General Health Care Bureau

  • Health Care Helpline: 1-877-305-5145
  • Can intervene informally with insurers
  • Assistance with complex appeal cases

Travere Therapeutics Support

Contact Travere's patient support program for:

  • Insurance navigation assistance
  • Copay support program eligibility
  • Clinical trial information
From our advocates: We've seen success when patients work closely with their specialty pharmacy coordinator. One patient's case was expedited when Accredo's clinical team called the insurer directly to discuss the medical urgency of preventing recurrent kidney stones in a young adult with cystinuria.

Cost Assistance Programs

Manufacturer Support

Travere Therapeutics may offer:

  • Copay assistance for eligible commercially insured patients
  • Patient assistance programs for uninsured/underinsured
  • Prior authorization support services

Contact Travere directly or ask your specialty pharmacy about available programs.

Foundation Grants

Organizations that may provide assistance:

  • National Kidney Foundation
  • Rare disease foundations
  • State pharmaceutical assistance programs

Illinois-Specific Programs

Check eligibility for Illinois programs that may help with specialty medication costs, particularly if you have Medicaid or are Medicare-eligible.

When to Escalate

Escalate to state regulators if:

  • Appeals are improperly denied despite meeting medical necessity criteria
  • BCBSIL fails to meet Illinois appeal timelines
  • Procedural violations in the review process
  • Pattern of inappropriate denials for rare disease medications

Illinois Department of Insurance Complaint Process:

  1. File complaint online at IDOI website
  2. Include all denial letters, appeal responses, and clinical documentation
  3. Emphasize rare disease status and FDA approval for your condition
  4. Request investigation of utilization management practices

Counterforce Health helps patients and clinicians navigate complex prior authorization and appeal processes by analyzing denial letters and crafting evidence-based appeals tailored to specific payer policies. Our platform identifies the exact denial basis and generates targeted rebuttals using the right clinical evidence and procedural requirements.

Frequently Asked Questions

Q: How long does BCBS Illinois prior authorization take for Thiola? A: Standard PA decisions are made within 15 business days. Expedited reviews (for urgent cases) are completed within 24-72 hours.

Q: What if Thiola isn't on my formulary? A: Request a formulary exception through the same PA process. Emphasize the lack of therapeutic alternatives for cystinuria and FDA orphan drug status.

Q: Can I use any pharmacy for Thiola? A: No, BCBS Illinois requires use of in-network specialty pharmacies like Accredo. Out-of-network pharmacies may result in full cost responsibility.

Q: What happens if my appeal is denied? A: You can request external review through the Illinois Department of Insurance within 30 days. This involves an independent physician reviewer and is binding on the insurer.

Q: Does step therapy apply to Thiola? A: Typically yes - you must document trial and failure of conservative measures (hydration, alkalinization) before Thiola approval.

Q: How often do I need to renew prior authorization? A: Most approvals are for 6-12 months and require renewal with updated clinical documentation and monitoring results.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and procedures change frequently. Always verify current requirements with your specific insurance plan and consult with your healthcare provider about treatment decisions. For personalized assistance with insurance appeals, consider consulting with Counterforce Health or other qualified patient advocacy services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.